2. Signaling Pathways
  3. GPCR/G Protein
  4. Prostaglandin Receptor
  5. Prostaglandin Receptor Isoform
  6. Prostaglandin Receptor Activator

Prostaglandin Receptor Activator

Prostaglandin Receptor Activators (12):

Cat. No. Product Name Effect Purity
  • HY-108560
    (+)-Fluprostenol
    		Activator
    (+)-Fluprostenol is a potent agonist of PTGER2. (+)-Fluprostenol decreases the expression of Oviductal glycoprotein 1 (OVGP1).
  • HY-W612338
    9-Oxononanoic acid
    		Activator
    9-Oxononanoic acid (9-ONA) is secondary reaction product of lipid peroxidation. 9-Oxononanoic acid induces phospholipase A2 (PLA2) activity and thromboxane A2 (HY-113350) production (TXA2). 9-Oxononanoic acid induces the platelet aggregation in human blood. 9-Oxononanoic acid is orally active.
  • HY-130304
    8-Isoprostaglandin E2
    		Activator ≥99.0%
    8-Isoprostaglandin E2 (iPE2-III) is a member of the isoprostane class of prostanoids. 8-Isoprostaglandin E2 acts at the receptor for thromboxane A2 (the TP) in vivo to induce vasoconstriction and platelet aggregation. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.
  • HY-124241
    N-Cyclopropyl bimatoprost
    		Activator
    N-Cyclopropyl bimatoprost (Formula II), a prostaglandin analog, can be used in the study of epithelial-related conditions.
  • HY-108560A
    15(S)-Fluprostenol
    		Activator
    15(S)-Fluprostenol is the isomer of (+)-Fluprostenol (HY-108560). (+)-Fluprostenol is a potent agonist of PTGER2. (+)-Fluprostenol decreases the expression of Oviductal glycoprotein 1 (OVGP1).
  • HY-137567
    Prostaglandin E1 ethanolamide
    		Activator
    Prostaglandin E1 ethanolamide is an analog of prostaglandin E1 (PGE1) and may effectively inhibit GLI2-induced expression of target genes, including Gli1 and Ptch1, and tumor growth.
  • HY-B0360S
    Rebamipide-d4
    		Activator ≥99.0%
    Rebamipide-d4 is deuterium labeled Rebamipide. Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner[1].
  • HY-126819
    Prostaglandin H1
    		Activator
    Prostaglandin H1 (PGH1), the cyclooxygenase metabolite of DGLA, is also a CRTh2 agonist and precursor for the anti-inflammatory prostaglandins of the 1-series. Prostaglandin H1 can be used in the study of inflammation.
  • HY-108560R
    (+)-Fluprostenol (Standard)
    		Activator
    (+)-Fluprostenol (Standard) is the analytical standard of (+)-Fluprostenol. This product is intended for research and analytical applications. (+)-Fluprostenol is a potent agonist of PTGER2. (+)-Fluprostenol decreases the expression of Oviductal glycoprotein 1 (OVGP1).
  • HY-117717
    (Rac)-SC-31391
    		Activator
    (Rac)-SC-31391, a prostaglandin analog, is a strong activator of the bladder muscle contractility that enhanced twitch responses elicited by field stimulation in the guinea pig detrusor muscle. (Rac)-SC-31391 contracts human bladder muscle through the activation of PGF2α receptors.
  • HY-114623
    Prostaglandin D2 methyl ester
    		Activator
    Prostaglandin D2 methyl ester is a prodrug form of Prostaglandin D2. Prostaglandin D2 methyl ester binds to the human and mouse PGD2 receptors (DP and CRTH2) with Ki values of 160 nM, 175 nM, 460 nM, and 270 nM for mCRTH2, mDP, hCRTH2, and hDP, respectively.
  • HY-101988R
    Prostaglandin D2 (Standard)
    		Activator
    Prostaglandin D2 (Standard) is the analytical standard of Prostaglandin D2. This product is intended for research and analytical applications. Prostaglandin D2 (PGD2) is one of the major PGs actively produced in the brain of various mammals. Prostaglandin D2 is one of the most potent endogenous sleep promoting substances. PGD2 plays a protective role by suppressing inflammation.